Underwriting AgreementUnderwriting Agreement • February 8th, 2018 • BioAmber Inc. • Industrial organic chemicals • New York
BioAmber Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters signatory hereto and named in Schedule I hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of (i) 32,300,000 Series A Units (the “Series A Units”), with each Series A Unit consisting of one share (the “Shares”) of common stock, par value $0.01 per share (“Common Stock”), of the Company, 32,300,000 Series A warrants to purchase one share of Common Stock (the “Series A Warrants”) and 32,300,000 Series B warrants to purchase one share of Common Stock (the “Series B Warrants”) and (ii) 7,700,000 Series B Units (the “Series B Units”), with each Series B Unit consisting of one prefunded warrant to purchase one share of Common Stock (the “Prefunded Warrants”) , 7,700,000 Series A Warrants to purchase one share of Common Stock and 7,700,000 Series B Warrants to purchase one share of Co
